At this time, posts about Medytox are rapidly increasing on portals and securities communities. Today, foreigners have tentatively net bought 1,000 shares of Medytox, while institutions have net sold 2,000 shares. Medytox is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.


As of 12:30 PM on the 17th, Medytox's stock price is 218,900 KRW, up 1.3% from the previous day, with a trading volume of 1,114,592 shares, which is 666.17% of the 5-day average trading volume. On December 10th, Medytox became an issue in the market with the news of "additional indictment of CEO Jeong Hyun-ho causing weakness."


In addition to Medytox, posts by investors are also rapidly increasing for Daewoong (003090), Sewoon Medical (100700), and Novatech (285490).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing